Regional Analysis of the Magnetization Transfer Ratio of the Brain in Mild Alzheimer Disease and Amnestic Mild Cognitive Impairment

REFERENCES

1. 1.↵
   1. Henry MS,
   2. Passmore AP,
   3. Todd S,
   4. et al

   . The development of effective biomarkers for Alzheimer's disease: a review. Int J Geriatr Psychiatry 2013;28:331–40.

   CrossRefPubMed
2. 2.↵
   1. Winblad B,
   2. Palmer K,
   3. Kivipelto M,
   4. et al

   . Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–46

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Petersen RC,
   2. Trojanowski JQ

   . Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice. JAMA 2009;302:436–37

   CrossRefPubMed
4. 4.↵
   1. Ramani A,
   2. Jensen JH,
   3. Helpern JA

   . Quantitative MR imaging in Alzheimer's disease. Radiology 2006;241:26–43

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Risacher SI,
   2. Saykin AJ,
   3. West JD,
   4. et al

   . Baseline MRI predictors of conversion from MCI to probable AD in the ADNI Cohort. Curr Alzheimer Res 2009;6:347–61

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Frisoni GB,
   2. Ganzola R,
   3. Canu E,
   4. et al

   . Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla. Brain 2008;131:3266–76

   Abstract/FREE Full Text
7. 7.↵
   1. Cavedo E,
   2. Boccardi M,
   3. Ganzola R,
   4. et al

   . Local amygdala structural differences with 3T MRI in patients with Alzheimer disease. Neurology 2011;76:726–33
8. 8.↵
   1. Poulin SP,
   2. Dautoff R,
   3. Morris JC,
   4. et al

   . Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity. Psychiatr Res Neuroimaging 2011;194:7–13

   CrossRef
9. 9.↵
   1. Hanyu H,
   2. Asano H,
   3. Sakurai M,
   4. et al

   . Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer's disease. J Neurol Sci 2001;188:79–84

   CrossRefPubMedWeb of Science
10. 10.↵
    1. van der Flier WM,
    2. van den Heuvel DM,
    3. Weverling-Rijnsburger AW,
    4. et al

    . Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 2002;52:62–67

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Van Es ACGM,
    2. van der Flier WM,
    3. Admiraal Behloul F,
    4. et al

    . Lobar distribution of changes in gray matter and white matter in memory clinic patients: detected using magnetization transfer imaging. AJNR Am J Neuroradiol 2007;28:1938–42

    Abstract/FREE Full Text
12. 12.↵
    1. Ridha BH,
    2. Symms MR,
    3. Tozer DJ,
    4. et al

    . Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements. AJNR Am J Neuroradiol 2007;28:965–70

    Abstract/FREE Full Text
13. 13.↵
    1. Ridha HB,
    2. Tozer DJ,
    3. Symms MR,
    4. et al

    . Quantitative magnetization transfer imaging in Alzheimer disease. Radiology 2007;244:832–37

    CrossRefPubMed
14. 14.↵
    1. Kiefer C,
    2. Brockhaus L,
    3. Cattapan-Ludewig K,
    4. et al

    . Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: the impact of quantitative magnetization transfer imaging. NeuroImage 2009;48:657–67

    CrossRefPubMed
15. 15.↵
    1. Giulietti G,
    2. Bozzali M,
    3. Figura V,
    4. et al

    . Quantitative magnetization transfer provides information complementary to grey matter atrophy in Alzheimer's disease brain. NeuroImage 2012;59:1114–22

    CrossRefPubMed
16. 16.↵
    1. Wiest R,
    2. Burren Y,
    3. Hauf M,
    4. et al

    . Classification of mild cognitive impairment and Alzheimer disease using model-based MR and magnetization transfer imaging. AJNR Am J Neuroradiol 2013;34:740–46

    Abstract/FREE Full Text
17. 17.↵
    1. Bozzali M,
    2. Franceschi M,
    3. Falini A,
    4. et al

    . Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 2001;57:1135–37

    CrossRef
18. 18.↵
    1. Ropele S,
    2. Schmidt R,
    3. Enzinger C,
    4. et al

    . Longitudinal magnetization transfer imaging in mild to severe Alzheimer disease. AJNR Am J Neuroradiol 2012;33:570–75

    Abstract/FREE Full Text
19. 19.↵
    1. Kabani NJ,
    2. Sled JG,
    3. Shuper A,
    4. et al

    . Regional magnetization transfer ratio changes in mild cognitive impairment. Magn Reson Med 2002;47:143–48

    CrossRefPubMed
20. 20.↵
    1. Kabani NJ,
    2. Sled JG,
    3. Chertkow H

    . Magnetization transfer ratio in mild cognitive impairment and dementia of Alzheimer's type. NeuroImage 2002;15:604–10

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Draganski B,
    2. Ashburner J,
    3. Hutton C,
    4. et al

    . Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxel-based quantification (VBQ). NeuroImage 2011;55:1423–34

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Bracco L,
    2. Amaducci L,
    3. Pedone D,
    4. et al

    . Italian Multicentre Study on Dementia (SMID): a neuropsychological test battery for assessing Alzheimer's disease. J Psychiatr Res 1990;24:213–26

    CrossRefPubMedWeb of Science
23. 23.↵
    1. McKhann G,
    2. Drachman D,
    3. Folstein M,
    4. et al

    . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human ServicesTask Force on Alzheimer's disease. Neurology 1984;34:939–44

    CrossRefPubMed
24. 24.↵
    1. Fazekas F,
    2. Chawluk JB,
    3. Alavi A,
    4. et al

    . MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNR Am J Neuroradiol 1987;149:351–56
25. 25.↵
    1. Jenkinson M,
    2. Bannister P,
    3. Brady JM,
    4. et al

    . Improved optimisation for the robust and accurate linear registration and motion correction of brain images. NeuroImage 2002;17:825–41

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Jost G,
    2. Hähnel S,
    3. Heiland S,
    4. et al

    . An automated method for volumetric quantification of magnetization transfer of the brain. Magn Reson Imaging 2002;20:593–97

    CrossRefPubMed
27. 27.↵
    1. Franke K,
    2. Luders E,
    3. May A

    . Brain maturation: predicting individual BrainAGE in children and adolescents using structural MRI. NeuroImage 2012;63:1305–12

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Ashburner J,
    2. Friston KJ

    . Unified segmentation. NeuroImage 2005;26:839–51

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Tohka J,
    2. Zijdenbos A,
    3. Evans A

    . Fast and robust parameter estimation for statistical partial volume models in brain MRI. NeuroImage 2004;23:84–97

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Rajapakse JC,
    2. Giedd JN,
    3. Rapoport JL

    . Statistical approach to segmentation of single-channel cerebral MR images. IEEE Trans Med Imaging 1997;16:176–86

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Cuadra MB,
    2. Cammoun L,
    3. Butz T,
    4. et al

    . Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Trans Med Imaging 2005;24:1548–65

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Gaser C

    . Partial volume segmentation with adaptive maximum a posteriori (MAP) approach. NeuroImage 2009;47:S121
33. 33.↵
    1. Fischl B

    . FreeSurfer. NeuroImage 2012 62:774–81

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Witten IH,
    2. Frank E,
    3. Hall MA

    . Data Mining: Practical Machine Learning Tools and Techniques, 3rd ed. Burlington, Massachusetts: Margan Kaufmann; 2011
35. 35.↵
    1. Castellani RJ,
    2. Rolston RK,
    3. Smith MA

    . Alzheimer disease. Dis Mon 2010;56:484–546

    CrossRefPubMed
36. 36.↵
    1. Janota I,
    2. Mountjoy CQ

    . Asymmetry of pathology in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1988;51:1011–12

    FREE Full Text
37. 37.↵
    1. Stefanits H,
    2. Budka H,
    3. Kovacs GG

    . Asymmetry of neurodegenerative disease-related pathologies: a cautionary note. Acta Neuropathol 2012;123:449–52

    CrossRefPubMed
38. 38.↵
    1. Derflinger S,
    2. Sorg C,
    3. Gaser C,
    4. et al

    . Grey-matter atrophy in Alzheimer's disease is asymmetric but not lateralized. J Alzheimers Dis 2011;25:347–57

    PubMedWeb of Science
39. 39.↵
    1. Mitchell AJ,
    2. Shiri-Feshki M

    . Rate of progression of mild cognitive impairment to dementia–meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;119:252–65

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Petersen RC,
    2. Smith GE,
    3. Waring SC,
    4. et al

    . Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–08

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Pennanen C,
    2. Testa C,
    3. Laakso MP,
    4. et al

    . A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry 2005;76:11–14

    Abstract/FREE Full Text
42. 42.↵
    1. Kalus P,
    2. Slotboom J,
    3. Gallinat J,
    4. et al

    . Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia. NeuroImage 2006;30:713–20

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Han Y,
    2. Lui S,
    3. Kuang W,
    4. et al

    . Anatomical and functional deficits in patients with amnestic mild cognitive impairment. PLoS One 2012;7:e28664

    CrossRefPubMed
44. 44.↵
    1. Chetelat GB,
    2. Landeau F.,
    3. Eustache,
    4. et al

    . Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. NeuroImage 2005;27:934–46

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Cercignani M,
    2. Symms MR,
    3. Schmierer K,
    4. et al

    . Three-dimensional quantitative magnetisation transfer imaging of the human brain. NeuroImage 2005;27:436–41

    CrossRefPubMed